ANSELL LIMITED (ANN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ANN - ANSELL LIMITED

Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Ansell is an Australian manufacturer of protective industrial equipment and household and medical gloves. It is the remnant of Pacific Dunlop, once a mighty conglomerate that listed in 1985. The name was changed to Ansell in 2002.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$28.11

08 Dec
2022

-0.330

OPEN

$28.31

-1.16%

HIGH

$28.53

164,458

LOW

$28.08

TARGET
$28.493 1.4% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
ASB . LGD . SRV . KPG . AIM . CUP . QHL . DGL .
FNARENA'S MARKET CONSENSUS FORECASTS
ANN: 1
Title FY23
Forecast
FY24
Forecast
EPS (cps) 170.8 xxx
DPS (cps) 75.1 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 16.6 xxx
Dividend Yield 2.7% xxx
Div Pay Ratio(%) 44.0% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 2.78%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.89

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/08 - ex-div 45.27c (franking 0%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx172.6
DPS All xxxxxxxxxxxxxxx78.9
Sales/Revenue xxxxxxxxxxxxxxx2,691.8 M
Book Value Per Share xxxxxxxxxxxxxxx1,782.7
Net Operating Cash Flow xxxxxxxxxxxxxxx278.8 M
Net Profit Margin xxxxxxxxxxxxxxx8.13 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx10.16 %
Return on Invested Capital xxxxxxxxxxxxxxx7.75 %
Return on Assets xxxxxxxxxxxxxxx6.00 %
Return on Equity xxxxxxxxxxxxxxx10.16 %
Return on Total Capital xxxxxxxxxxxxxxx11.84 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx66.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

11/11/2022

3

Equal-weight

$28.77

2.35%

AGM commentary noted downside risk to FY23 revenues for Ansell, moderated somewhat by some easing in costs, SG&A restraint and a  tax expense at the lower end of the range, observes Morgan Stanley.

Management expects to achieve an FY23 EPS outcome at the lower end of its US115c-US135c range. Consensus and Morgan Stanley are currently at US124c and US121c, respectively.

Given an uncertain outlook, the broker retains its Equal-weight rating and leaves its $28.77 target unchanged. Industry view In-Line.

FORECAST
Morgan Stanley forecasts a full year FY23 dividend of 69.52 cents and EPS of 171.95 cents.
Morgan Stanley forecasts a full year FY24 dividend of 83.29 cents and EPS of 205.95 cents.

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

xx/xx/xxxx

3

xxxxxxx xx xxxxxxx xxxx xxxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

ANN STOCK CHART